ARQT — Arcutis Biotherapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $1.25bn
- $1.09bn
- $59.61m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 101 | 284 | 387 | 410 | 272 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0.51 | 0.362 | 8.46 | 25.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 106 | 293 | 403 | 437 | 330 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.491 | 5.37 | 5.3 | 4.6 | 3.9 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 107 | 298 | 408 | 449 | 341 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.24 | 22.6 | 33.3 | 37.8 | 46.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.55 | 27.6 | 110 | 240 | 253 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 101 | 271 | 298 | 210 | 88.7 |
Total Liabilities & Shareholders' Equity | 107 | 298 | 408 | 449 | 341 |
Total Common Shares Outstanding |